These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 27903247)
1. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247 [TBL] [Abstract][Full Text] [Related]
2. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
3. Preoperative long-course chemoradiotherapy plus adjuvant chemotherapy versus short-course radiotherapy without adjuvant chemotherapy both with delayed surgery for stage II-III resectable rectal cancer: 5-Year survival data of a randomized controlled trial. Kairevičė L; Latkauskas T; Tamelis A; Petrauskas A; Paužas H; Žvirblis T; Jaruševičius L; Saladžinskas Ž; Pavalkis D; Jančiauskienė R Medicina (Kaunas); 2017; 53(3):150-158. PubMed ID: 28690144 [TBL] [Abstract][Full Text] [Related]
4. Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: A comparison of the short- and long-term outcomes in patients with T3 rectal cancer. Beppu N; Matsubara N; Noda M; Yamano T; Kakuno A; Doi H; Kamikonya N; Kimura F; Yamanaka N; Yanagi H; Tomita N Surgery; 2015 Jul; 158(1):225-35. PubMed ID: 25900036 [TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M J BUON; 2013; 18(2):385-90. PubMed ID: 23818350 [TBL] [Abstract][Full Text] [Related]
6. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057 [TBL] [Abstract][Full Text] [Related]
10. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis. Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093 [TBL] [Abstract][Full Text] [Related]
12. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634 [TBL] [Abstract][Full Text] [Related]
13. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365 [TBL] [Abstract][Full Text] [Related]
14. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study. Bosch SL; Verhoeven RHA; Lemmens VEPP; Simmer F; Poortmans P; de Wilt JHW; Nagtegaal ID Virchows Arch; 2019 Dec; 475(6):745-755. PubMed ID: 31463728 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications. Wang Y; Wang X; Chen J; Huang S; Huang Y Updates Surg; 2024 Jun; 76(3):949-962. PubMed ID: 38240957 [TBL] [Abstract][Full Text] [Related]
16. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Bonnetain F; Bosset JF; Gerard JP; Calais G; Conroy T; Mineur L; Bouché O; Maingon P; Chapet O; Radosevic-Jelic L; Methy N; Collette L Eur J Cancer; 2012 Aug; 48(12):1781-90. PubMed ID: 22507892 [TBL] [Abstract][Full Text] [Related]
17. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Latkauskas T; Pauzas H; Gineikiene I; Janciauskiene R; Juozaityte E; Saladzinskas Z; Tamelis A; Pavalkis D Colorectal Dis; 2012 Mar; 14(3):294-8. PubMed ID: 21899712 [TBL] [Abstract][Full Text] [Related]
18. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy. Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy. Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453 [TBL] [Abstract][Full Text] [Related]
20. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]